Study That Tests AD109 in Patients Taking GLP-1 Drugs
Clinical trial NCT06400615 · COMPLETED
Trial details
- NCT number
- NCT06400615
- Sponsor
- Apnimed
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2024-12-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.